Monsanto Company (NYSE:MON) was downgraded by investment analysts at Vetr from a “buy” rating to a “hold” rating in a research report issued on Tuesday. They presently have a $118.00 price objective on the stock. Vetr‘s target price suggests a potential upside of 3.68% from the company’s previous close.
Other equities research analysts have also recently issued reports about the stock. Zacks Investment Research upgraded shares of Monsanto Company from a “strong sell” rating to a “hold” rating in a report on Tuesday, November 29th. Sanford C. Bernstein set a $105.00 target price on shares of Monsanto Company and gave the company a “neutral” rating in a research note on Thursday, January 5th. CLSA upgraded shares of Monsanto Company from an “underperform” rating to an “outperform” rating in a research note on Friday, January 6th. They noted that the move was a valuation call. Finally, Royal Bank of Canada began coverage on shares of Monsanto Company in a research note on Thursday, February 23rd. They issued a “sector perform” rating and a $118.00 target price for the company. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and fifteen have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $116.15.
Monsanto Company (NYSE:MON) opened at 113.81 on Tuesday. The company has a market capitalization of $49.91 billion, a price-to-earnings ratio of 31.21 and a beta of 0.93. The company has a 50-day moving average price of $111.17 and a 200-day moving average price of $105.77. Monsanto Company has a one year low of $84.79 and a one year high of $116.04.
Monsanto Company (NYSE:MON) last released its quarterly earnings results on Thursday, January 5th. The company reported $0.21 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.01 by $0.20. Monsanto Company had a net margin of 11.61% and a return on equity of 47.05%. The company earned $2.22 billion during the quarter. During the same quarter last year, the company earned ($0.11) earnings per share. The firm’s revenue was up 19.4% on a year-over-year basis. Equities research analysts anticipate that Monsanto Company will post $4.74 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 28th. Stockholders of record on Friday, April 7th will be issued a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a dividend yield of 1.90%. The ex-dividend date of this dividend is Wednesday, April 5th. Monsanto Company’s payout ratio is 58.86%.
Your IP Address:
In other news, EVP Steven Mizell sold 2,525 shares of the firm’s stock in a transaction that occurred on Tuesday, January 10th. The shares were sold at an average price of $108.56, for a total transaction of $274,114.00. Following the completion of the sale, the executive vice president now owns 43,711 shares of the company’s stock, valued at $4,745,266.16. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Michael K. Stern sold 5,670 shares of the firm’s stock in a transaction that occurred on Wednesday, January 25th. The stock was sold at an average price of $110.00, for a total transaction of $623,700.00. Following the sale, the chief executive officer now directly owns 20,534 shares of the company’s stock, valued at approximately $2,258,740. The disclosure for this sale can be found here. Company insiders own 0.79% of the company’s stock.
Hedge funds have recently bought and sold shares of the company. Israel Discount Bank of New York GFN purchased a new stake in Monsanto Company during the fourth quarter valued at $140,000. Norges Bank purchased a new stake in Monsanto Company during the fourth quarter valued at $406,735,000. Sowell Financial Services LLC purchased a new stake in Monsanto Company during the fourth quarter valued at $480,000. Luminus Management LLC purchased a new stake in Monsanto Company during the fourth quarter valued at $14,596,000. Finally, PagnatoKarp Partners LLC purchased a new stake in Monsanto Company during the fourth quarter valued at $491,000. 75.18% of the stock is owned by institutional investors.
Monsanto Company Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.